PMID- 32939494
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220416
IS  - 2666-6383 (Electronic)
IS  - 2666-6383 (Linking)
VI  - 4
IP  - 3
DP  - 2020 Sep
TI  - Quantifying the minimal and substantial clinical benefit of the Constant-Murley 
      score and the Disabilities of the Arm, Shoulder and Hand score in patients with 
      calcific tendinitis of the rotator cuff.
PG  - 606-611
LID - 10.1016/j.jseint.2020.05.001 [doi]
AB  - BACKGROUND: To aid the interpretation of clinical outcome scores, it is important 
      to determine the measurement properties. The aim of this study was to establish 
      the minimal clinically important difference (MCID) and substantial clinical 
      benefit (SCB) for the Constant-Murley score and Disabilities of the Arm, Shoulder 
      and Hand score in patients with long-lasting rotator cuff calcific tendinitis 
      treated with high-energy extracorporeal shockwave therapy and ultrasound guided 
      needling. The secondary purpose was to assess the responsiveness of both 
      questionnaires and to identify variables associated with achieving the MCID and 
      SCB. METHODS: A prospective cohort of 80 patients with rotator cuff calcific 
      tendinitis was analyzed. Two anchor-based methods were used to calculate the MCID 
      and SCB. Effect sizes and standardized response means were calculated to assess 
      the responsiveness. Additional univariate logistic regression analyses were 
      performed to identify factors associated with the achievement of the MCID and 
      SCB. RESULTS: For the Constant-Murley score, we found an MCID and SCB of 9.8 and 
      19.9, respectively, based on the mean change method and 5.5 and 10.5, 
      respectively, based on receiver operating characteristic analysis. For the 
      Disabilities of the Arm, Shoulder and Hand score, we found an MCID and SCB of 
      -8.2 and -19.6, respectively, with the former and -11.7 and -12.5, respectively, 
      with the latter. The responsiveness of both outcome measures was good, with large 
      effect sizes and standardized response means. The radiographic resorption after 6 
      weeks and after 6 months appeared to be the most important positive predictor for 
      achieving the MCID and SCB after 6 months. CONCLUSION: This study established the 
      MCID, SCB, and responsiveness for patients with long-lasting rotator cuff 
      calcific tendinitis who were treated with minimally invasive treatment options. 
      With this information, physicians can distinguish between a statistically 
      significant difference and a clinically relevant benefit. Successful radiographic 
      resorption after 6 weeks and after 6 months was associated with achieving 
      clinically significant improvement after treatment.
CI  - (c) 2020 The Authors.
FAU - Louwerens, Jan K G
AU  - Louwerens JKG
AD  - Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.
FAU - van den Bekerom, Michel P J
AU  - van den Bekerom MPJ
AD  - Department of Orthopaedic Surgery, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, 
      The Netherlands.
FAU - van Royen, Barend J
AU  - van Royen BJ
AD  - Department of Orthopaedic Surgery, Amsterdam University Medical Centers, 
      Amsterdam, The Netherlands.
FAU - Eygendaal, Denise
AU  - Eygendaal D
AD  - Department of Orthopaedic Surgery, Amsterdam University Medical Centers, 
      Amsterdam, The Netherlands.
AD  - Department of Orthopaedic Surgery, Amphia, Breda, The Netherlands.
FAU - van Noort, Arthur
AU  - van Noort A
AD  - Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.
FAU - Sierevelt, Inger N
AU  - Sierevelt IN
AD  - Department of Orthopaedic Surgery, Spaarne Gasthuis, Hoofddorp, The Netherlands.
LA  - eng
PT  - Journal Article
DEP - 20200606
PL  - United States
TA  - JSES Int
JT  - JSES international
JID - 101763461
PMC - PMC7479032
OTO - NOTNLM
OT  - Rotator cuff calcific tendinitis
OT  - minimal clinically important difference
OT  - minimally invasive treatment
OT  - outcome measures
OT  - prognostic factors
OT  - substantial clinical benefit
EDAT- 2020/09/18 06:00
MHDA- 2020/09/18 06:01
PMCR- 2020/06/06
CRDT- 2020/09/17 05:45
PHST- 2020/09/17 05:45 [entrez]
PHST- 2020/09/18 06:00 [pubmed]
PHST- 2020/09/18 06:01 [medline]
PHST- 2020/06/06 00:00 [pmc-release]
AID - S2666-6383(20)30078-5 [pii]
AID - 10.1016/j.jseint.2020.05.001 [doi]
PST - epublish
SO  - JSES Int. 2020 Jun 6;4(3):606-611. doi: 10.1016/j.jseint.2020.05.001. eCollection 
      2020 Sep.